Network meta-analysis of survival data with fractional polynomials

Abstract

BackgroundPairwise meta-analysis, indirect treatment comparisons and network meta-analysis for aggregate level survival data are often based on the reported hazard ratio, which relies on the proportional hazards assumption. This assumption is implausible when hazard functions intersect, and can have a huge impact on decisions based on comparisons of expected survival, such as cost-effectiveness analysis.MethodsAs an alternative to network meta-analysis of survival data in which the treatment effect is represented by the constant hazard ratio, a multi-dimensional treatment effect approach is presented. With fractional polynomials the hazard functions of interventions compared in a randomized controlled trial are modeled, and the difference between the parameters of these fractional polynomials within a trial are synthesized (and indirectly compared) across studies.ResultsThe proposed models are illustrated with an analysis of survival data in non-small-cell lung cancer. Fixed and random effects first and second order fractional polynomials were evaluated.Conclusion(Network) meta-analysis of survival data with models where the treatment effect is represented with several parameters using fractional polynomials can be more closely fitted to the available data than meta-analysis based on the constant hazard ratio.

Systematic Review and Network Meta-Analysis of Overall Survival Comparing 3 mg/kg Ipilimumab With Alternative Therapies in the Management of Pretreated Patients With Unresectable Stage III or IV Melanoma

“…An NMA of the published Kaplan-Meier survival curves was performed for the RCTs according to Jansen [28] and Ouwens et al [29]. With this approach, the observed data represented with the Kaplan-Meier curve of each drug class in each study was described with a survival function consisting of a scale and shape parameter.…”

“…The corresponding hazard was based on a binomial likelihood distribution [28,29]. Whenever available, the numbers of patients at risk as reported below the published Kaplan-Meier curves were used to deduct the numbers at risk for specific time windows.…”

Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

“…This assumption has been shown to be violated for abiraterone (12). The ERG noted that methods are available for incorporating HRs that vary over time (17), but were not considered for this study. The company used the results from a fixed-effects NMA.…”

Second-Line Treatments For Advanced Gastric Cancer: A Network Meta-Analysis Of Overall Survival Using Parametric Modelling Methods

“…Alternative methods have been proposed to avoid the proportional hazards assumption in meta-analyses; Jansen [4] presents the application of fractional polynomials to synthesise data for treatment of non-small cell lung carcinoma and Ouwens [5] applies a Weibull model within a network meta-analysis (NMA), comparing interventions for treatment of multiple myeloma. Cope [6] extended methods proposed by Ouwens [5], fitting a series of parametric models within an NMA for second-line treatment of advanced breast cancer.…”